Literature DB >> 1544757

Risk factors for fatal venous thromboembolism in young women: a case-control study.

M Thorogood1, J Mann, M Murphy, M Vessey.   

Abstract

A case-control study of fatal venous thromboembolism in young women is described. Sixty women aged between 16 and 39 who died from thromboembolism in England and Wales between 1986 and 1988 were included in the study. Two living controls matched for age and marital status were sought from the records of the general practitioner with whom each case was registered. Some 115 controls were included in the study. The cases had a significantly higher prevalence of a history of major illness, particularly thrombotic episodes, than the controls. The odds ratio (OR) of a fatal thromboembolism in women who had a history of venous thrombosis was 4.0 (95% Cl: 1.4-11.5). There was also a significantly higher frequency of a recent operation or accident amongst the cases than the controls (OR = 11.1, 95% Cl: 1.3-92.5). There was no significant excess or oral contraceptive use amongst the cases. The overall OR associated with current use of oral contraceptives was 1.6 (95% Cl: 0.7-3.4), while the corresponding OR for 'idiopathic' diseases was 2.1 (95% Cl: 0.8-5.2). These risks are considerably smaller than those observed in previous studies. The observed risk may be low because the dosage of oestrogen in modern oral contraceptive preparations has been reduced, but it may also be because the cases of fatal venous thromboembolism included in this study represent only a small proportion of all cases of venous thrombeombolism; a disease which is rarely fatal in young women. These results cannot necessarily be extrapolated to nonfatal venous thromboembolism.

Entities:  

Keywords:  Behavior; Case Control Studies; Contraception; Contraceptive Methods; Demographic Factors; Developed Countries; Diseases; Embolism; England; Europe; Evaluation; Family Planning; Mortality; Northern Europe; Oral Contraceptives; Oral Contraceptives, Low-dose; Population; Population Dynamics; Research Methodology; Research Report; Risk Assessment; Smoking; Studies; Thromboembolism; United Kingdom; Vascular Diseases; Wales

Mesh:

Substances:

Year:  1992        PMID: 1544757     DOI: 10.1093/ije/21.1.48

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

1.  Use of oral contraceptives by adolescents and its consequences in Finland 1981-91.

Authors:  A H Rimpelä; M K Rimpelä; E A Kosunen
Journal:  BMJ       Date:  1992-10-31

Review 2.  Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lamberto Manzoli; Corrado De Vito; Carolina Marzuillo; Antonio Boccia; Paolo Villari
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

Review 3.  Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives.

Authors:  P C Hannaford; V Owen-Smith
Journal:  BMJ       Date:  1998-03-28

4.  Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study.

Authors:  Michel K Barsoum; John A Heit; Aneel A Ashrani; Cynthia L Leibson; Tanya M Petterson; Kent R Bailey
Journal:  Thromb Res       Date:  2010-09-15       Impact factor: 3.944

5.  Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.

Authors:  Pansakorn Tanratana; Paul Ellery; Pamela Westmark; Alan E Mast; John P Sheehan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-02       Impact factor: 8.311

Review 6.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

7.  Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women.

Authors:  Joel G Ray; Loralie J Langman; Marian J Vermeulen; Jovan Evrovski; Erik L Yeo; David EC Cole
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

8.  Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives.

Authors:  Paula Elizabeth Briggs; Cecile Aude Praet; Samantha Charlotte Humphreys; Changgeng Zhao
Journal:  J Fam Plann Reprod Health Care       Date:  2013-01-07

9.  Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.

Authors:  Alain Weill; Marie Dalichampt; Fanny Raguideau; Philippe Ricordeau; Pierre-Olivier Blotière; Jérémie Rudant; François Alla; Mahmoud Zureik
Journal:  BMJ       Date:  2016-05-10

10.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

Authors:  A van Hylckama Vlieg; F M Helmerhorst; J P Vandenbroucke; C J M Doggen; F R Rosendaal
Journal:  BMJ       Date:  2009-08-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.